Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 97: 1119-1128, 2004; doi:10.1152/japplphysiol.00035.2004
8750-7587/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prior, B. M.
Right arrow Articles by Terjung, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prior, B. M.
Right arrow Articles by Terjung, R. L.

INVITED REVIEW

HIGHLIGHTED TOPICS
Skeletal and Cardiac Muscle Blood Flow

What makes vessels grow with exercise training?

Barry M. Prior,1 H. T. Yang,1 and Ronald L. Terjung1,2,3

1Department of Biomedical Sciences, College of Veterinary Medicine, 2Department of Medical Pharmacology and Physiology, College of Medicine, and 3Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211


    ABSTRACT
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Exercise and muscle contractions create a powerful stimulus for structural remodeling of the vasculature. An increase in flow velocity through a vessel increases shear stress, a major stimulus for enlargement of conduit vessels. This leads to an endothelial-dependent, nitric oxide-dependent enlargement of the vessel. Increased flow within muscle, in the absence of contractions, leads to an enhanced capillarity by intussusceptive angiogenesis, a process of capillary splitting by intraluminal longitudinal divide. In contrast, sprouting angiogenesis requires extensive endothelial cell proliferation, with degradation of the extracellular matrix to permit migration and tube formation. This occurs during muscle adaptations to chronic contractions and/or muscle overload. The angiogenic growth factor VEGF appears to be an important element in angiogenesis. Recent advances in research have identified hemodynamic and mechanical stimuli that upregulate angiogenic processes, demonstrated a complexity of potent growth factors and interactions with their corresponding receptors, detected an interaction of cellular signaling events, and identified important tissue reorganization processes that must be coordinated to effect vascular remodeling. It is likely that much of this information is applicable to the vascular remodeling that occurs in response to exercise and/or muscle contractions.

angiogenesis; arteriogenesis; intussusception; sprouting; shear stress; mechanical stretch


BLOOD FLOW TO MUSCLE IS DETERMINED by the balance of central and peripheral influences operating on the existing "plumbing" of the vascular system. The structure of the vascular system is, in turn, designed in a manner to optimize tissue support through the processes of convection and diffusion. Simply described, the large conduit vessels of the systemic circuit permit bulk flow delivery to the relatively small resistance vessels within a muscle at high pressure. The resistance vessels modulate flow distribution to the microvascular network bathing the cells. The capillary network, in turn, functions to permit diffusive exchange (e.g., O2, CO2, glucose, and so forth) between the vascular space and the intracellular volume of the fibers. The focus of this work is to consider what structural changes occur in the vascular system with exercise training and to provide insight as to how these changes develop. In doing so, it is important to distinguish among the vascular segment(s) that may be changed. Enlargement of existing vessels, a process termed arteriogenesis, is an effective means of increasing blood flow capacity to downstream vascular elements. On the other hand, expansion of the capillary network, a process termed angiogenesis, is effective at improving exchange properties between blood and tissue. Table 1 summarizes factors that are generally important in vascular remodeling. In considering these different adaptations, it is important to distinguish among relevant stimuli that may be introduced by exercise. A number of excellent reviews on these topics are available (11, 12, 16, 21, 34, 43, 48, 77).


View this table:
[in this window]
[in a new window]
 
Table 1. Factors important in vascular remodeling

 

    THE PROCESSES OF VASCULAR REMODELING
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Arteriogenesis

Arteriogenesis is a term applied to the enlargement of existing arterial vessels. This enlargement is not simply distension of the vessel wall due to increased intraluminal pressure or an increase in wall compliance; rather, it is an increase in the caliber (diameter) and wall dimensions, resulting in a larger vessel. For this to occur, there must be remodeling of all three cell types that comprise the arterial vessel: endothelial cells, smooth muscle cells, and fibroblasts. In general, the larger the conduit artery, the thicker and more muscular and fibrous is the vessel wall. A number of excellent reviews summarize the advances in our understanding of arterial vessel enlargement (61, 77, 96).

Angiogenesis

Angiogenesis refers to the formation of new capillaries from existing capillaries. This is different from the process of vasculogenesis, which describes the de novo formation of the vasculature from precursor cells during development. In the absence of pathology (e.g., tumor growth, diabetic retinopathy), there are few physiological circumstances prompting angiogenesis, notably ovarian cycling, placental development, and exercise. Angiogenesis can occur by two primary mechanisms: intussusception and sprouting.

Capillary intussusception.   Intussusception refers to the process by which a single capillary splits into two capillaries from within, by the formation of a pillarlike structure or longitudinal divide on the luminal side of the capillary (see Fig. 1). Activated endothelial cells extend intraluminally, effectively forming two tubes through which blood can pass. This is thought to be an efficient process of capillary multiplication, requiring less endothelial cell proliferation and offering a greater simplicity in extracellular matrix remodeling, compared with sprouting angiogenesis (21). Recent research has suggested that intussusception may be the primary method of capillary formation during development (21, 51). It is likely that shear forces acting on capillaries may preferentially increase capillarity through intussusception (81). The novel contributions of Hudlicka and colleagues (23) have made significant progress in understanding angiogenesis in muscle challenged by elevated flow, stretch, and contractions. Future work will undoubtedly shed light on the intussusception method of capillary formation, the signaling pathways that lead to endothelial cell pillar formation, and its distinctions from sprouting angiogenesis.



View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1. Angiogenesis occurs by the processes of intussusception and sprouting.

 
Sprouting angiogenesis.   Capillary formation by endothelial cell sprouting refers to the process in which activated endothelial cells branch out from an existing capillary, extending through the surrounding matrix to form a cordlike structure (see Fig. 1). The endothelial cell cord is transformed into a tube and attached to the extracellular matrix. Of course, the newly formed tube must reenter the capillary bed by joining with another capillary or venule to become a functional capillary. The newly developed capillary is initially leaky, but it matures to that of the original capillary when pericytes envelop the endothelial cells. Like intussusception, sprouting requires the activation of endothelial cells. In addition, however, the basement membrane and the extracellular matrix must be degraded to permit migration of endothelial cells and expansion of the developing tube. Thus there must be a coordination of multiple processes for sprouting angiogenesis to proceed to completion (23, 42). For example, inhibiting the degradation of the extracellular matrix limits endothelial cell migration and tube formation (38). This could explain why the presence of some apparent angiogenic stimuli by themselves are not sufficient to produce an increase in capillarity.


    VASCULAR ADAPTATIONS WITH EXERCISE
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Flow Capacity Increases

It is now recognized that the flow capacity of skeletal muscle is far greater than can be supported by cardiac output, if a large mass of muscle would require maximal blood flow during exercise (4). Thus it seems unlikely that significant increases in flow capacity would be a necessary adaptation to support the increased exercise performance observed after training or in elite athletes. Nonetheless, there is general correspondence between the flow capacity of muscle and its biochemical and functional aerobic capacity. When specific muscles are exercise trained, there can be an increase in flow capacity (maximal conductance) (59, 65) and an expected increase in the caliber of the large conduit vessels. Unfortunately, there is little direct evidence, from controlled experiments employing exercise training, showing that major conduit arteries increase in size (86). This is likely due to the modest size increase necessary to appreciably increase flow capacity, since vessel resistance is a function of the radius to the fourth power. More importantly, it is probable that training programs, which are typically set up for experimental purposes, have not optimized the adaptive stimuli necessary to realize exceptional vessel enlargement because the program's exercise bout intensity and/or duration and overall training program duration may be limited. There is considerable evidence, however, that large flow increases introduced through a major conduit artery result in substantial enlargement of the vessel. Increasing blood flow through the carotid artery, by experimentally introducing an arteriovenous shunt, increased vessel diameter by ~75% (93). Thus it is not surprising that the size of major supply vessels in humans, determined by duplex sonography, scales in relation to the exercise and/or use pattern of the muscle groups supplied by these vessels (47). For example, Hounker and coworkers (47) reported that the subclavian arteries of the dominant arms of elite tennis players and athletes with paraplegia exhibited larger diameters than the respective contralateral and control group arteries. Similarly, increased diameters of the femoral arteries were observed in elite cyclists, whereas decreases were observed with paraplegia, compared with corresponding controls. Thus major conduit vessel size corresponded to activity pattern of the dependent muscle groups, even though the sizes of the great artery (thoracic and abdominal aorta) were not different among all of these groups. Although this evidence of vessel size is not ideal, representing maximal caliber and wall thickness of the vessel in the absence of smooth muscle tone, it is consistent with the known relationship between vessel caliber and vessel flow demand, both apparent within the vascular tree (aorta, iliac, femoral, popliteal, and so forth) and observed experimentally (93). This increase in flow capacity to the major muscle groups of highly trained individuals could contribute to the greater exercise capacity exhibited by these individuals.

Muscle Capillarity Increases

It has long been recognized that exercise training imparts a dramatic adaptation at the other end of the vascular tree (13). As illustrated in Fig. 2, capillarity in the active muscle is meaningfully increased by training, particularly endurance-type training (49). Although high-resistance training programs that result in muscle fiber hypertrophy can actually decrease capillary support, due to the increased fiber area (90), this is not always the case (56), especially if work bouts involve more repetitive contractions typically done by bodybuilders. Any increase in muscle capillarity should be important in enhancing blood-tissue exchange properties, since a greater capillary network would 1) increase the surface area for diffusion, 2) shorten the average diffusion path length within the muscle, and 3) increase the length of time for diffusive exchange between blood and tissue. For example, for any given blood flow to the muscle, a greater capillary volume would lengthen the red blood cell transit time and thereby permit a longer time for oxygen exchange. This expectation that trained muscle would exhibit an increased oxygen exchange capacity has been demonstrated in humans (78), dogs (44), and rats (104). In experiments with rat muscle (104), the increase in maximal oxygen consumption (and improvement in muscle performance) was observed when oxygen delivery was controlled to be similar to that of the nontrained muscle (104). Interestingly, although the increase in capillarity is associated with an increase the maximal oxygen consumption of muscle, there has been no experimental evidence, to our knowledge, demonstrating that the increased capillarity observed in trained muscle is required. Requisite evidence would come from studies in which all muscle adaptations typical of endurance training were induced, except for the increase in muscle capillarity. Furthermore, another factor or other factors appear to be important to this training adaptation. For example, an increase in mitochondrial electron transport capacity was essential to realize the training-induced increase in maximal oxygen consumption (82). It is also unclear just how an increase in capillarity may be functionally important. The value of an enhanced capillary density (i.e., greater capillary network per volume of muscle) was questioned by recent evidence in which oxygen exchange capacity was not improved in dog muscle, despite the same capillary network supplying a much smaller muscle mass as a result of induction of short-term muscle atrophy (44). It has been suggested that the important parameter representing the appropriate match in muscle capillarity is capillary surface area relative to fiber surface area (44), a parameter that increases in muscle after aerobic-type training.



View larger version (138K):
[in this window]
[in a new window]
 
Fig. 2. Angiogenesis increases capillarity in the superficial gastrocnemius muscle of the rat following endurance-type exercise training (B) compared with cage-sedentary control (A). Capillaries were stained for alkaline phosphatase activity and counterstained with metanil yellow and appear as dark brown circles or lines. Muscle fibers are stained yellow.

 

    FACTORS IMPLICATED IN ARTERIOGENESIS
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Enlargement of an arterial vessel occurs in response to elevated internal pressure (55, 85), which increases radial wall stress, and in response to increased blood flow (93), which elevates shear stress on the endothelial surface. Wall mass increases to manage the increased radial wall stress that occurs with high pressure or as vessel diameter increases, according to the Laplace relationship. Large, although short-lived, increases in arterial blood pressure can occur during intense resistance-type exercise (64). It is presently not known whether this type of exercise leads to structural changes in the affected vessels. On the other hand, increases in flow velocity through a given arterial vessel initiates extensive enlargement of the artery in the absence of any increase in luminal pressure. This stimulus is directly related to the increase in shear stress caused by the increased flow velocity (94), as the vessel enlarges to regulate shear stress back to "normal" (93). Conversely, if blood flow is reduced, the diameter of the artery decreases (57). Thus shear stress can be considered the primary hemodynamic stimulus that prompts vessel enlargement.

The entire process of vessel remodeling depends on the presence of the endothelium. In cultured endothelial cells, shear stress upregulates numerous factors implicated in arteriogenesis [e.g., VEGF receptor-2 (VEGFR2), integrin {alpha}v{beta}3, angiopoietin receptor Tie2, and endothelial nitric oxide synthase (eNOS) (77)]. Furthermore, increased shear experienced by the endothelium translates to a nitric oxide (NO)-dependent signal necessary for vessel enlargement (84) involving remodeling of the extracellular matrix (92). Experimentally inhibiting NO production with nitro-L-arginine methyl ester eliminates vessel enlargement, even though high flow conditions remain (93), whereas overexpression of eNOS enhances vessel enlargement (1). Thus the competency of endothelial NO production is very important in permitting vascular remodeling through arteriogenesis. Recognition that chronic physical activity upregulates eNOS (9, 60) implies that there is an improved responsiveness for vascular remodeling, compared with sedentary individuals. This may contribute to the general correspondence between an active lifestyle and the lower incidence of cardiovascular disease (14).

Inflammation.

There is substantial evidence that elements of the inflammatory response are involved in arteriogenesis, at least in collateral vessels after occlusion of a major conduit artery (12). Immediately after occlusion of the vessel, there is a dramatic upregulation of monocyte chemoattractant protein-1, particularly in the tissue where arteriogenesis is active. Invasion of monocytes in the region of the collaterals contributes to the vessel enlargement process, presumably through the release of potent cytokines [e.g., VEGF, fibroblast growth factor (FGF)-2] and/or monocyte-activating properties, as was the case with placenta growth factor-induced arteriogenesis through VEGF receptor-1 (VEGFR1) (75). Elimination of monocyte presence diminished and exogenous delivery of monocytes stimulated arteriogenesis (52, 75). Furthermore, there is developing evidence that bone marrow-derived endothelial progenitor cells (EPCs) are important in vessel remodeling (6). It is not known whether monocytes or EPCs are involved in any enlargement of conduit vessels induced by exercise, since there is no experimental evidence available. Furthermore, there has been no evaluation of possible monocyte and/or EPC participation in angiogenesis induced within active muscle by endurance-type exercise training, although EPCs have been identified in capillaries within muscle after hindlimb ischemia (6). There may be an expectation that monocyte infiltration could be important in capillary proliferation in active muscle. There is an inflammatory response within muscle at the onset of training, if the exercise task is intense, uncommon, and the muscle is "over used." However, it seems unlikely that this is critical to the expansion of the capillary network, since muscle soreness and inflammation are quickly resolved and do not occur with continued exercise; on the other hand, angiogenesis continues to completion later in time as the training continues. Interestingly, physical training has been shown to increase circulating EPCs, improve vascular repair after injury, and enhance angiogenesis in mice (58); it has also been shown to increase circulating EPCs and their survival in patients with stable coronary artery disease (58). Whether these findings have a broad application to humans during exercise training and/or are related to the beneficial effects of exercise on cardiovascular disease remains to be explored.


    FACTORS IMPLICATED IN ANGIOGENESIS
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Growth Factors

VEGF is a potent mitogen of endothelial cells that has been implicated in the angiogenic response to exercise. Although it is reasonable to expect that VEGF and other proangiogenic processes are important in both sprouting and intussusceptive angiogenesis, our present knowledge comes primarily from experiments evaluating sprouting angiogenesis. For example, on stimulation by VEGF, endothelial cells cultured on a collagen gel proliferate, migrate, and form sprouts that eventually appear as tubelike structures (31). In addition, VEGF serves as a chemoattractant (69), which may assist in endothelial cell migration, and has been shown to stimulate smooth muscle cell migration and proliferation (17). VEGF binds to two primary receptors on the endothelial cell: VEGFR1, a fms-like tyrosine kinase (Flt-1) receptor, and VEGFR2, originally termed the fetal liver kinase (Flk/KDR) receptor. VEGF-induced activation of VEGFR2 stimulates endothelial cell proliferation, migration, and differentiation in most cell cultures (8, 30, 99, 101). Activation of VEGFR2 elicits a potent tyrosine kinase signaling cascade, which includes activation of phosphoinositol-3-kinase, phospholipase C-{gamma}, and protein kinase C-{epsilon} (101), to stimulate gene expression for a variety of genes, including eNOS (87). In addition, VEGFR2 activation leads to NO production through eNOS via mobilization of intracellular Ca2+ stores (18). NO production can be critical to VEGF signaling, since inhibiting NO production diminishes responses to otherwise potent angiogenic stimuli (50, 74). It has been generally accepted that VEGF activation of VEGFR2 elicits the complete angiogenic response (16). Indeed, Milkiewicz et al. (70) observed a high correlation between VEGFR2 protein expression and capillary proliferation induced with muscle activity. Although there is much to be learned about the control of angiogenesis in vivo, VEGF and its binding to receptors must be considered a critical element (2).

Other angiogenic or proangiogenic growth factors can also contribute to angiogenesis. For example, FGF (e.g., FGF-2) is a potent mitogen for endothelial cells, smooth muscle cells, and fibroblasts. Furthermore, FGF-2 can upregulate VEGF (89) and NO production (7). However, FGF-2 does not appear to be upregulated by exercise (35, 79), and its content within trained muscle does not change, even though there was an increased capillarity induced by the training program (20) or with muscle overload (22). Nonetheless, FGF-2 may contribute to the continuation of angiogenesis as it is released from storage sites on degradation of the extracellular matrix (98). The angiopoietins (Ang1 and Ang2) are important cytokines that are not mitogenic to endothelial cells but assist in vascular development and remodeling (24). Ang1 promotes maturation and stabilization of vessels and is expressed widely throughout tissues, whereas Ang2 competes with Ang1 by displacing it from activating the Tie2 receptor and is expressed at sites of vascular remodeling. Thus Ang1 dominance is associated with a stable vasculature, and Ang2 dominance is associated with active angiogenesis. Other cytokines are also implicated in angiogenesis. Activated endothelial cells produce platelet-derived growth factor and transforming growth factor-{beta}, which can recruit pericytes to help complete the newly formed capillary (69). Although a complexity of multiple cytokines and their actions are involved in angiogenesis, VEGF appears to be central in the process of initiating angiogenesis.

Upregulation of VEGF with exercise.   Upregulation of VEGF occurs in rat muscle following contractions (2, 5, 40) or with a single bout of moderately intense treadmill running (10). In the latter case, VEGF mRNA was upregulated in the active muscle of rats approximately two- to fourfold by the end of exercise, remained elevated for the next ~4 h, but returned to that of rested muscle within 8 h postexercise. Upregulation of VEGF mRNA also occurs during exercise in humans, in both normal healthy individuals (35, 79) and patients with heart failure (32). Increases in VEGF protein are coincident with these increases in VEGF mRNA after exercise (33). However, a decrease in muscle VEGF protein content has been observed during exercise (25). Muscle VEGF contents may be mobilized as VEGF increases in the interstitium (46) and released by active muscle (45). Thus there is ample reason to expect that mobilization and upregulation of VEGF are important events in the exercise-induced increase in muscle capillarity that occurs with training. Indeed, Armaral and coworkers demonstrated that the angiogenesis induced within muscle by chronic stimulation (2) and treadmill running (3) was dependent on the availability of VEGF.

Although experiments to define a clear relationship between the stimulus (exercise dose), VEGF upregulation, and angiogenesis have not been performed, it does appear that VEGF is primarily upregulated in the fibers that undergo angiogenesis. Lloyd et al. (62) observed a relatively modest increase in VEGF mRNA in the fast-twitch red region of the gastrocnemius, compared with the fast-twitch white gastrocnemius region, 2 h after treadmill running with restricted blood flow to the calf muscles. The fast-twitch red region of the gastrocnemius receives approximately fourfold greater blood flow than that measured in the white gastrocnemius section during these exercise conditions (63, 103). Thus the red region has a relative surfeit of blood flow during exercise, compared with the white gastrocnemius region. More importantly, subsequent to the approximately sixfold increase in VEGF mRNA, the white region exhibited a significant increase in muscle capillarity within 10–14 days (62), whereas similar training in a previous study did not produce any change in capillarity in the red gastrocnemius region (105). It should be pointed out, however, that in the basal condition it is the red gastrocnemius region that enjoys a relative rich capillary density, approximately three times that measured in the white gastrocnemius region (37). In fact, basal expression of VEGF mRNA is approximately threefold higher in this high-oxidative red region, compared with the white region of the gastrocnemius (62). Furthermore, VEGF protein content appears to scale with tissue vascularity among fiber types, as well as after muscle remodeling that increases capillarity (5). Thus the abundance of VEGF mRNA and protein and the upregulation during contractions appear to vary with vascular density and/or active angiogenesis.

Exercise also upregulates other elements that may be important to the angiogenic process. For example, the mRNA of the VEGF receptors VEGFR1 and VEGFR2 are upregulated after muscle activity (26, 28, 62). If this translates into an increase in receptor protein, as observed with electrical stimulation by Milkiewicz et al. (70), there could be an enhanced tissue responsiveness to VEGF and an amplification of the angiogenic cascade. Exercise has been shown to upregulate eNOS mRNA (62) and protein (97). This could have major implications for angiogenesis because NO production is an important element of VEGF signaling (63, 71). Curiously, inhibiting NO production during training in flow-restricted muscle did not alter the angiogenesis induced by treadmill running (63). Thus there may be other important stimuli, established by active force development and shortening, that interact with the VEGF-mediated angiogenesis pathway (see Mechanical Stretch). Completion of the angiogenic process in active muscle likely involves the angiopoietins. The ratio of Ang2/Ang1 is markedly elevated after an exercise bout and throughout a 3-wk duration of training in muscle undergoing angiogenesis (62). This is expected to favor vascular expansion in the presence of VEGF (66). Although there have been no definitive demonstrations of these events, the evidence developed to date is consistent with this interpretation.

Extracellular Matrix Degradation

Although VEGF appears to be essential for angiogenesis, degradation of the basement membrane surrounding the capillary is necessary for sprouting angiogenesis to proceed. Proteolysis of the basement membrane is achieved by several families of enzymes: matrix metalloproteinases (MMPs), plasminogen, and the urokinase and tissue plasminogen activators (uPA, tPA). This process of extracellular matrix degradation must be highly controlled and coordinated because unguarded dissolution of the extracellular matrix would result in a loss of the integrity, and thereby function, of the microvasculature. Thus a balance of controlling influences must be altered to shift from a situation of stability of the microvasculature to one permitting remodeling of the extracellular matrix and sprouting angiogenesis. Important in this balance are the tissue-localized inhibitors of MMPs (TIMPs). For example, specific ratios of MMPs to TIMPs are needed for efficient activation of some MMPs (39). MMPs are secreted as inactive propeptides and are activated by cleavage of the regulatory peptide sequence. Activation of MMPs is achieved by plasmin and other MMPs. For example, uPA activates plasmin (from plasminogen), which in turn activates MMP-3 (stromelysin) and in turn activates MMP-9 (39). Activation of MMP-2 and activation of MMP-9 appear to be important proteolytic events facilitating angiogenesis. Similarly, uPA is proangiogenic, and PA inhibitor PAI-1 exhibits antiangiogenic effects (16). VEGF-mediated signaling upregulates uPA and tPA activity and mRNA expression (53, 67, 68). Although there is very little information as to how these processes are coordinated to support angiogenesis induced by muscle activity, some interesting studies have confirmed the important of the MMPs. Rivilis et al. (81) observed an increase in MMP-2 activity and an upregulation of membrane type-1 (MT1)-MMP (i.e., MMP-14) in muscle after overload. MMP-14 has been shown to be upregulated in endothelial cells on exposure to strain in culture (102). This implies that physical stretch developed during contractions could be an important contributor to angiogenesis. In another important study, Haas et al. (38) found that inhibiting the MMPs eliminated the expansion of the capillary network induced by chronic muscle stimulation, although proliferation of endothelial cells continued. It is hoped that future work will add significant new understanding to the remodeling events of the extracellular matrix during angiogenesis induced within active muscle. As described below, the work of Haas, Hudlicka, and coworkers (11, 23, 38, 41, 81, 107, 108) have been instrumental in illuminating our understanding of factors prompting angiogenesis in adult muscle, including the MMPs.


    HYPOXIA
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
One of the most potent stimuli that initiates capillary angiogenesis is hypoxia. Hypoxia exerts its effect primarily through an upregulation of VEGF and the sequelae thereby established. Lowering the PO2 of endothelial cells in culture stimulates cell proliferation, migration, and tube formation, whereas returning the culture medium PO2 to a high value reduces VEGF expression and lessens endothelial cell activation (88). Although it remains unclear how low PO2 is sensed, there is a marked increase in a transcription factor, hypoxia-inducible factor (HIF-1{alpha}; both mRNA and protein), which stimulates transcription of the VEGF gene (88). The half-life of HIF-1{alpha} is short lived and subject to modulation. HIF-1 also controls other proteins important in angiogenesis (e.g., VEGFR1; Ref. 29) and is engaged in gene regulation of other hypoxia-sensitive responses (e.g., erythropoietin production at altitude). It is important to appreciate that the role of hypoxia should be relegated to angiogenesis in active muscle, where the PO2 can be low, and not to arteriogenesis, where the endothelium of the arterial conduit vessel is perfused with high PO2 blood. The importance of hypoxia as an obvious candidate for the initiation of angiogenesis in active muscle during training was reinforced by data showing that hypoxia enhanced the exercise-induced upregulation of VEGF in rat muscle (10). More recent experiments confirmed the likely involvement of HIF-1{alpha} by demonstrating an elevation in HIF-1{alpha} mRNA and protein during exercise in humans (36). However, further experimental pursuit of this process in humans led to equivocal results in which exercise in hypoxic/ischemic conditions did not enhance the upregulation of VEGF, compared with exercise in normoxic/hyperemic conditions (35, 79). Thus, although the HIF levels vary within a physiologically relevant range of PO2 (54), no relationship between the PO2 within the active muscle and the VEGF mRNA response was established (79). This conundrum implies that either exercise in normoxia produces a sufficiently low, essentially a "saturated" PO2 response within the active muscle, and that reducing the PO2 further is superfluous or that other factors are involved in modulating the signaling cascade upregulating VEGF.

The upregulation of VEGF in active muscle during exercise is even more intriguing. Wagner and coworkers reported that the large increase in VEGF mRNA initially observed after a bout of exercise was not sustained over subsequent days of training in animals (27) or humans (80). This response pattern was confirmed with ischemic training and shown to occur at a time when angiogenesis was ongoing and became measurable on histochemical evaluation (62). Although adaptations in the cellular environment within the active muscle have likely occurred to ameliorate the VEGF upregulation, it does not seem likely that a significant protection against a low PO2 occurred in this experiment (62), since the animals performed relatively ischemic exercise caused by occlusion of the femoral arteries. Furthermore, Olfert et al. observed that chronic exposure to hypoxia decreased resting mRNA levels of VEGF and its receptors (73) and attenuated their increase during exercise (72) but that it did not eliminate the increase in muscle capillarity with training (73). Thus there is no simple relationship between muscle PO2 during exercise, the upregulation of VEGF, and the putative development of angiogenesis. It is likely that stimuli other than low PO2 are important in angiogenesis in contracting muscle.


    SHEAR STRESS AND MECHANICAL STRETCH
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Although much evidence shows that mechanical forces, related to shear stress and/or mechanical stretch, can initiate signals that remodel the vasculature, it has been difficult to establish experiments that quantitatively impart and/or control these stimuli and relate them to the angiogenic outcome in the microvasculature of muscle in vivo. This is due to the difficulty in measuring or controlling the stimulus of shear stress and/or mechanical stretch actually experienced by the cells within the muscle in vivo. Nonetheless, there have been some important observations that attest to distinctions in the signaling and angiogenic outcome with different types of mechanical stimuli.

Shear Stress

Prolonged delivery of vasodilators to rats increases capillarity of skeletal muscle (91). Chronic administration of an {alpha}-sympathetic blocker (prazosin) increased muscle blood flow approximately threefold (109). This produced a significant increase in red blood cell velocity through the capillaries and an increase in calculated shear stress experienced by the endothelium (19). This work has provided the foundation for the subsequent use of prazosin in evaluating the effects of increased shear stress on capillary and arteriolar remodeling in muscle (23, 76, 95, 108). Most importantly, the nature of this flow-mediated angiogenic response appears to be distinct. The increased capillarity induced by elevating shear stress was achieved primarily by intussusceptive angiogenesis (23, 108), in contrast to that observed with muscle overload (11, 22, 107) or probably exercise training (11). By exhaustive analyses of high-resolution micrographs, Hudlicka and coworkers (23, 108) were able to identify a marked elevation in the frequency of capillaries with longitudinal divides on the luminal side of the capillary. Furthermore, these investigators subsequently reported that activation of MMP-2 and MT1-MMP was not evident with flow-mediated intussusceptive angiogenesis, again in contrast to that observed in sprouting angiogenesis (81). However, in keeping with signaling events induced by shear stress in large arteries, VEGF is implicated in angiogenesis as both VEGF protein accumulation and endothelial cell proliferation were observed in both intussusceptive angiogenesis and sprouting angiogenesis (81). The absence of an upregulation of VEGF during high flow conditions in quiescent dog muscle (83) does not necessarily dismiss the importance of this growth factor in flow-mediated angiogenesis. In that experiment, blood flows achieved in the high oxidative capacity, high vascular capacity muscle in the absence of contractions may not have produced similar flow profiles within the microvasculature as achieved during contractions. Furthermore, shear stress can activate the VEGFR2 pathway, independent of VEGF (100). Thus an elevated shear stress is likely an important mechanical signal prompting angiogenesis within muscle.

Mechanical Stretch

In addition to the intussusceptive angiogenesis associated with increased blood flow, there is evidence for sprouting angiogenesis in skeletal muscle. Muscle overload, by ablation of synergists (11, 22, 107), and muscle contractions, in response to chronic intermittent nerve stimulation (11), lead to sprouting angiogenesis. In both of these experimental treatments, contraction of the muscle leads to mechanical forces acting on the tissue that could initiate angiogenesis, in the former case by performing the work of synergist and in the latter by the unaccustomed frequency of contractions. Stretch of cells in culture upregulates VEGF (mRNA and protein), leads to enhanced endothelial cells migration and tube formation (106), activates MT1-MMP (102), and upregulates Ang2 and Tie2 expression (15). All of these actions would support sprouting angiogenesis if they occurred within active muscle. Although blood flow is expected to be increased during contractions, thereby establishing an increase in shear stress, it is reasonable to expect that mechanical forces developed within active muscle are a stimulus that fosters sprouting angiogenesis.

VEGF is elevated in muscle with treatments of hyperemia, overload, and contractions. Thus the presence of this growth factor does not seem to be a feature in distinguishing sprouting vs. intussusceptive angiogenesis, although there is no clear resolution of its relation to endothelial cell proliferation (11). There is, however, compelling evidence of a distinction in the response of the MMPs. MMP-2 activity and MT1-MMP mRNA were elevated by muscle overload but not with muscle hyperemia (81). Recall that extracellular matrix degradation is an essential element permitting sprouting angiogenesis to proceed. Indeed, Haas et al. (38) demonstrated that inhibition of MMP activity eliminated the angiogenesis typically induced by muscle stimulation. This work provides the first example of how coordinated processes must be orchestrated in order for angiogenesis to continue to completion in active muscle. Furthermore, there is evidence that this angiogenesis prompted by chronic nerve stimulation requires NO production in its signaling pathway. Administration of a NOS inhibitor eliminated the increase in muscle capillarity typically observed (50). Presently, we are only beginning to understand how muscle contractions induce angiogenesis. It is anticipated that future research will help clarify which angiogenic process is initiating by mechanical and/or hemodynamic stimuli in active muscle.


    SUMMARY
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Research in recent years has resulted in an appreciation of the many angiogenic growth factors, critical receptors, signaling pathways, and their coordinated interactions that must be involved in vascular remodeling. In addition, controlled studies have exposed important chemical and mechanical stimuli that initiate and propagate the angiogenic process. This is particularly evident in a shear stress-mediated enlargement of conduit vessels. It is likely that much of this information is applicable to the events within active muscle to increase capillarity and to improve muscle function. However, there is much research needed to understand how this physiological angiogenesis is controlled to accommodate the demands within active muscle.


    GRANTS
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Cited work of the authors was supported by National Heart, Lung, and Blood Institute Grants HL-10485 and HL-37387.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank Don Conner for preparing the illustration.


    FOOTNOTES
 

Address for reprint requests and other correspondence: R. L. Terjung, Biomedical Sciences, College of Veterinary Medicine, E102 Vet Med Bldg., Univ. of Missouri, Columbia, MO 65211 (E-mail: terjungr{at}missouri.edu).


    REFERENCES
 TOP
 ABSTRACT
 THE PROCESSES OF VASCULAR...
 VASCULAR ADAPTATIONS WITH...
 FACTORS IMPLICATED IN...
 FACTORS IMPLICATED IN...
 HYPOXIA
 SHEAR STRESS AND MECHANICAL...
 SUMMARY
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Amano K, Matsubara H, Iba O, Okigaki M, Fujiyama S, Imada T, Kojima H, Nozawa Y, Kawashima S, Yokoyama M, and Iwasaka T. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41: 156–162, 2003.[Abstract/Free Full Text]
  2. Amaral SL, Linderman RJ, Morse MM, and Greene AS. Angiogenesis induced by electrical stimulation is mediated by angiotensins II and VEGF. Microcirculation 8: 57–67, 2001.[CrossRef][Web of Science][Medline]
  3. Amaral SL, Papanek PE, and Greene AS. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol 281: H1163–H1169, 2001.[Abstract/Free Full Text]
  4. Andersen P and Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 366: 233–249, 1985.[Abstract/Free Full Text]
  5. Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, and Kraus WE. Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol Heart Circ Physiol 274: H860–H867, 1998.[Abstract/Free Full Text]
  6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner KM, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221–228, 1999.[Abstract/Free Full Text]
  7. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, and Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 82: 1007–1015, 1998.[Abstract/Free Full Text]
  8. Bernatchez PN, Soker S, and Sirois MG. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 274: 31047–31054, 1999.[Abstract/Free Full Text]
  9. Bowles DK, Woodman CR, and Laughlin MH. Coronary smooth muscle and endothelial adaptations to exercise training. Exerc Sport Sci Rev 28: 57–62, 2000.[Medline]
  10. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, and Wagner PD. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81: 355–361, 1996.[Abstract/Free Full Text]
  11. Brown MD and Hudlicka O. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6: 1–14, 2003.[CrossRef][Medline]
  12. Buschmann I, Heil M, Jost M, and Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10: 371–379, 2003.[CrossRef][Web of Science][Medline]
  13. Carrow RE, Brown RE, and Van Hess WD. Fiber sizes and capillary to fiber ratios in skeletal muscle of exercised rats. Anat Rec 159: 33–39, 1967.[CrossRef][Medline]
  14. Chakravarthy MV and Booth FW. Exercise. Philadelphia, PA: Hanley & Belfus, 2003.
  15. Chang H, Wang BW, Kuan P, and Shyu KG. Cyclic mechanical stretch enhances angiopoietin-2 and Tie2 receptor expression in cultured human umbilical vein endothelial cells. Clin Sci (Lond) 104: 421–428, 2003.[Medline]
  16. Conway EM, Collen D, and Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49: 507–521, 2001.[Free Full Text]
  17. Cucina A, Borrelli V, Randone B, Coluccia P, Sapienza P, and Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res 109: 16–23, 2003.[CrossRef][Web of Science][Medline]
  18. Cunningham SA, Tran TM, Arrate MP, Bjercke R, and Brock TA. KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells. Am J Physiol Cell Physiol 276: C176–C181, 1999.[Abstract/Free Full Text]
  19. Dawson JM and Hudlicka O. The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23: 913–920, 1989.[Web of Science][Medline]
  20. Deschenes MR and Ogilvie RW. Exercise stimulates neovascularization in occluded muscle without affecting bFGF content. Med Sci Sports Exerc 31: 1599–1604, 1999.
  21. Djonov V, Baum O, and Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 314: 107–117, 2003.[CrossRef][Web of Science][Medline]
  22. Egginton S, Hudlicka O, Brown MD, Walter H, Weiss JB, and Bate A. Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl Physiol 85: 2025–2032, 1998.[Abstract/Free Full Text]
  23. Egginton S, Zhou AL, Brown MD, and Hudlicka O. Unorthodox angiogenesis in skeletal muscle. Cardiovasc Res 49: 634–646, 2001.[Abstract/Free Full Text]
  24. Gale NW and Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13: 1055–1066, 1999.[Free Full Text]
  25. Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, and Hickner RC. Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol 96: 19–24, 2004.[Abstract/Free Full Text]
  26. Gavin TP, Spector DA, Wagner H, Breen EC, and Wagner PD. Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J Appl Physiol 88: 1690–1697, 2000.[Abstract/Free Full Text]
  27. Gavin TP and Wagner PD. Effect of short-term exercise training on angiogenic growth factor gene responses in rats. J Appl Physiol 90: 1219–1226, 2001.[Abstract/Free Full Text]
  28. Gavin TP and Wagner PD. Attenuation of the exercise-induced increase in skeletal muscle Flt-1 mRNA by nitric oxide synthase inhibition. Acta Physiol Scand 175: 201–209, 2002.[CrossRef][Web of Science][Medline]
  29. Gerber HP, Condorelli F, Park J, and Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is upregulated by hypoxia. J Biol Chem 272: 23659–23667, 1997.[Abstract/Free Full Text]
  30. Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, and Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor specific vascular endothelial growth factor mutants. J Biol Chem 276: 3222–3230, 2001.[Abstract/Free Full Text]
  31. Goto F, Goto K, Weindel K, and Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508–517, 1993.[Web of Science][Medline]
  32. Gustafsson T, Bodin K, Sylven C, Gordon A, Tyni-Lenne R, and Jansson E. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest 31: 362–366, 2001.[CrossRef][Web of Science][Medline]
  33. Gustafsson T, Knutsson A, Puntschart A, Kaijser L, Nordqvist AC, Sundberg CJ, and Jansson E. Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training. Pflügers Arch 444: 752–759, 2002.[CrossRef][Web of Science][Medline]
  34. Gustafsson T and Kraus WE. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci 6: 75–89, 2001.
  35. Gustafsson T, Puntschart A, Kaijser L, Jansson E, and Sundberg CJ. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 276: H679–H685, 1999.[Abstract/Free Full Text]
  36. Gustafsson T, Puntschart A, Sundberg CJ, and Jansson E. Related expression of vascular endothelial growth factor and hypoxia-inducible factor-1 mRNAs in human skeletal muscle. Acta Physiol Scand 165: 335–336, 1999.[CrossRef][Web of Science][Medline]
  37. Gute D, Fraga C, Laughlin MH, and Amann JF. Regional changes in capillary supply in skeletal muscle of high-intensity endurance-trained rats. J Appl Physiol 81: 619–626, 1996.[Abstract/Free Full Text]
  38. Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD, Madri JA, and Hudlicka O. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279: H1540–H1547, 2000.[Abstract/Free Full Text]
  39. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, Nagase H, French DL, and Quigley JP. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann NY Acad Sci 878: 372–387, 1999.[CrossRef][Web of Science][Medline]
  40. Hang J, Kong L, Gu JW, and Adair TH. VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol Heart Circ Physiol 269: H1827–H1831, 1995.[Abstract/Free Full Text]
  41. Hansen SF, Egginton S, Zhou AL, and Hudlicka O. Growth of arterioles precedes that of capillaries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 62: 1–14, 2001.[CrossRef][Web of Science][Medline]
  42. Hansen-Smith FM, Hudlicka O, and Egginton S. In vivo angiogenesis in adult rat skeletal muscle: early changes in capillary network architecture and ultrastructure. Cell Tissue Res 286: 123–136, 1996.[CrossRef][Web of Science][Medline]
  43. Helisch A and Schaper S. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10: 83–97, 2003.[CrossRef][Web of Science][Medline]
  44. Hepple RT, Hogan MC, Stary C, Bebout DE, Mathieu-Costello O, and Wagner PD. Structural basis of muscle O2 diffusing capacity: evidence from muscle function in situ. J Appl Physiol 88: 560–566, 2000.[Abstract/Free Full Text]
  45. Hiscock N, Fischer CP, Pilegaard H, and Pedersen BK. Vascular endothelial growth factor mRNA expression and arteriovenous balance in response to prolonged, submaximal exercise in humans. Am J Physiol Heart Circ Physiol 285: H1759–H1763, 2003.[Abstract/Free Full Text]
  46. Hoffner L, Nielsen JJ, Langberg H, and Hellsten Y. Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in humans skeletal muscle interstitium. J Physiol 550: 217–225, 2003.[Abstract/Free Full Text]
  47. Hounker M, Schmid A, Schmidt-Trucksass A, Grathwohl D, and Keul J. Size and blood flow of central and peripheral arteries in highly trained able-bodied and disabled athletes. J Appl Physiol 95: 685–691, 2003.[Abstract/Free Full Text]
  48. Hudlicka O. Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5: 7–23, 1998.[Medline]
  49. Hudlicka O, Brown MD, and Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369–417, 1992.[Free Full Text]
  50. Hudlicka O, Brown MD, and Silgram H. Inhibition of capillary growth in chronically stimulated rat muscles by N(G)-nitro-L-arginine, nitric oxide synthase inhibitor. Microvasc Res 59: 45–51, 2000.[CrossRef][Web of Science][Medline]
  51. Hurz H, Burre PH, and Djonov V. Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci 18: 65–70, 2003.[Abstract/Free Full Text]
  52. Ito WD, Arrasi M, Winkler B, Scholz D, Schaper J, and Schaper W. Monocytochemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80: 829–837, 1997.[Abstract/Free Full Text]
  53. Iwasaka C, Tanaka K, Abe M, and Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169: 522–531, 1996.[CrossRef][Web of Science][Medline]
  54. Jiang BH, Semenza GL, Hugo CB, and Marti H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol Cell Physiol 271: C1172–C1180, 1996.[Abstract/Free Full Text]
  55. Koffi I, Safar ME, Labat C, Lacolley P, Benetos A, and Mourad JJ. Arterial structural changes with verapamil in spontaneously hypertensive rats. Am J Hypertens 12: 732–738, 1999.[CrossRef][Web of Science][Medline]
  56. Kraemer WJ, Fleck SJ, and Evans WJ. Strength and power training: physiological mechanisms of adaptation. Exerc Sport Sci Rev 24: 363–397, 1996.[Medline]
  57. Langille BL and O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405–407, 1986.[Abstract/Free Full Text]
  58. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, and Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220–226, 2004.[Abstract/Free Full Text]
  59. Laughlin MH, Korthuis RJ, Duncker DJ, and Bache RJ. Control of blood flow to cardiac and skeletal muscle during exercise. In: Handbook of Physiology. Exercise. Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc., 1996, sect. 12, chapt. 16, p. 705–769.
  60. Laughlin MH, Welshons WV, Sturek M, Rush JW, Turk JR, Taylor JA, Judy BM, Henderson KK, and Ganjam VK. Gender, exercise training, and eNOS expression in porcine skeletal muscle arteries. J Appl Physiol 95: 250–264, 2003.[Abstract/Free Full Text]
  61. Lehoux S, Tronc F, and Tedgui A. Mechanisms of blood flow-induced vascular enlargement. Biorheology 39: 319–324, 2002.[Web of Science][Medline]
  62. Lloyd PG, Prior BM, Yang HT, and Terjung RL. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol 284: H1668–H1678, 2003.[Abstract/Free Full Text]
  63. Lloyd PG, Yang HT, and Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2528–H2538, 2001.[Abstract/Free Full Text]
  64. MacDougall JD, Tuxen D, Sale DG, Moroz JR, and Sutton JR. Arterial blood pressure response to heavy resistance exercise. J Appl Physiol 58: 785–790, 1985.[Abstract/Free Full Text]
  65. Mackie BG and Terjung RL. Influence of training on blood flow to different skeletal muscle fiber types. J Appl Physiol 55: 1072–1078, 1983.[Abstract/Free Full Text]
  66. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, and Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55–60, 1997.[Abstract/Free Full Text]
  67. Mandriota SJ and Pepper MS. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110: 2293–2302, 1997.[Abstract]
  68. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, and Pepper MS. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270: 9709–9716, 1995.[Abstract/Free Full Text]
  69. Matsumoto T and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001: RE21, 2001.
  70. Milkiewicz M, Hudlicka O, Verhaeg J, Egginton S, and Brown MD. Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity. Clin Sci (Colch) 105: 473–482, 2003.[Medline]
  71. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, and Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol Heart Circ Physiol 270: H411–H4115, 1996.[Abstract/Free Full Text]
  72. Olfert IM, Breen EC, Mathieu-Costello O, and Wagner PD. Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J Appl Physiol 90: 1532–1538, 2001.[Abstract/Free Full Text]
  73. Olfert IM, Breen EC, Mathieu-Costello O, and Wagner PD. Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J Appl Physiol 91: 1176–1184, 2001.[Abstract/Free Full Text]
  74. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, and Ziche M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273: 4220–4226, 1998.[Abstract/Free Full Text]
  75. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, and Clauss M. VEGFR-1-selective VEGF homologue PlGF is arteriogenic evidence for a monocyte-medicated mechanism. Circ Res 92: 378–385, 2003.[Abstract/Free Full Text]
  76. Price RJ and Skalak TC. Chronic {alpha}1-adrenergic blockade stimulates terminal and arcade arteriolar development. Am J Physiol Heart Circ Physiol 271: H752–H759, 1996.[Abstract/Free Full Text]
  77. Resnick N, Einav S, Chen-Konak L, Zilberman M, Yahav H, and Shay-Salit A. Hemodynamic forces as a stimulus for arteriogenesis. Endothelium 10: 197–206, 2003.[Web of Science][Medline]
  78. Richardson RS, Grassi B, Gavin TP, Haseler LJ, Tagore K, Roca J, and Wagner PD. Evidence of O2 supply-dependent O2 max in the exercise-trained human quadriceps. J Appl Physiol 86: 1048–1053, 1999.[Abstract/Free Full Text]
  79. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, and Wagner PD. Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol Heart Circ Physiol 277: H2247–H2252, 1999.[Abstract/Free Full Text]
  80. Richardson RS, Wagner H, Mudaliar SRD, Saucedo E, Henry R, and Wagner PD. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol 279: H772–H778, 2000.[Abstract/Free Full Text]
  81. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, and Haas TL. Differential involvement of MMP-2 and VEGF during muscle stretch- vs. shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283: H1430–H1438, 2002.[Abstract/Free Full Text]
  82. Robinson DM, Ogilvie RW, Tullson PC, and Terjung RL. Increased peak oxygen consumption of trained muscle requires increased electron flux capacity. J Appl Physiol 77: 1941–1952, 1994.[Abstract/Free Full Text]
  83. Roca J, Gavin TP, Jordan M, Siafakas N, Wagner H, Benoit H, Breen E, and Wagner PD. Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscle. J Appl Physiol 85: 1142–1149, 1998.[Abstract/Free Full Text]
  84. Rudic RD, Shesely EG, Maedo N, Smithies O, Segal SS, and Sessa WC. Direct evidence for the important of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731–736, 1998.[Web of Science][Medline]
  85. Saleh FH and Jurjus AR. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker. J Pathol 193: 415–420, 2001.[CrossRef][Web of Science][Medline]
  86. Segal SS, Kurjiaka DT, and Caston AL. Endurance training increases arterial wall thickness in rats. J Appl Physiol 74: 722–726, 1993.[Abstract/Free Full Text]
  87. Shen BQ, Lee DY, and Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 33057–33063, 1999.[Abstract/Free Full Text]
  88. Shweiki D, Itin A, Soffer D, and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845, 1992.[CrossRef][Medline]
  89. Stavri GT, Zachary IC, Baskerville PA, Martin JF, and Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 92: 11–14, 1995.[Abstract/Free Full Text]
  90. Tesch PA, Thorsson A, and Kaiser P. Muscle capillary supply and fiber type characteristics in weight and power lifters. J Appl Physiol 56: 35–38, 1984.[Abstract/Free Full Text]
  91. Tornling G, Adolfsson J, Unge G, and Ljungqvist A. Capillary neoformation in skeletal muscle of dipyridamole-treated rats. Arzneimittelforschung 30: 791–792, 1980.[Medline]
  92. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, and Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 20: E120–E126, 2000.[Web of Science]
  93. Tronc F, Wassef M, Exposito B, Henrion D, Glagov S, and Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 16: 1256–1262, 1996.[Abstract/Free Full Text]
  94. Tuttle JL, Nachreiner RD, Bhuller AS, Condict KW, Connors BA, Herring BP, Dalsing MC, and Unthank JL. Shear level influences resistance artery remodeling: wall dimension, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 281: H1380–H1389, 2001.[Abstract/Free Full Text]
  95. Van Gieson EJ and Skalak TC. Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during microvascular remodeling in rat skeletal muscle. Microcirculation 8: 25–31, 2001.[CrossRef][Web of Science][Medline]
  96. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, and Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49: 543–553, 2001.[Abstract/Free Full Text]
  97. Vassilakopoulos T, Deckman G, Kebbewar M, Rallis G, Harfouche R, and Hussain SN. Regulation of nitric oxide production in limb and ventilatory muscles during chronic exercise training. Am J Physiol Lung Cell Mol Physiol 284: L452–L457, 2003.[Abstract/Free Full Text]
  98. Vlodavsky I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, and Klagsbrun M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem 45: 167–176, 1991.[CrossRef][Web of Science][Medline]
  99. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, and Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988–26995, 1994.[Abstract/Free Full Text]
  100. Wang Y, Chang JM, Li YC, Li YS, Shyy JY, and Chien S. Shear stress and VEGF activate IKK via Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 286: H685–H692, 2004.[Abstract/Free Full Text]
  101. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, and Donner DB. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275: 5096–5103, 2000.[Abstract/Free Full Text]
  102. Yamaguchi S, Yamaguchi M, Yatsuyanagi E, Yun SS, Nakajima N, Madri JA, and Sumpio BE. Cyclic strain stimulates early growth response gene product 1-medicated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest 82: 949–956, 2002.[Web of Science][Medline]
  103. Yang HT, Laughlin MH, and Terjung RL. Prior exercise training increases collateral-dependent blood flow in rats after acute femoral artery occlusion. Am J Physiol Heart Circ Physiol 279: H1890–H1897, 2000.[Abstract/Free Full Text]
  104. Yang HT, Ogilvie RW, and Terjung RL. Peripheral adaptations in trained aged rats with femoral artery stenosis. Circ Res 74: 235–243, 1994.[Abstract/Free Full Text]
  105. Yang HT, Ogilvie RW, and Terjung RL. Exercise training enhances basic fibroblast growth factor-induced collateral blood flow. Am J Physiol Heart Circ Physiol 274: H2053–H2061, 1998.[Abstract/Free Full Text]
  106. Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, and Tomanek RL. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-{beta}. Am J Physiol Heart Circ Physiol 280: H909–H917, 2001.[Abstract/Free Full Text]
  107. Zhou AL, Egginton S, Brown MD, and Hudlicka O. Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study. Anat Rec 252: 49–63, 1998.[CrossRef][Medline]
  108. Zhou AL, Egginton S, Hudlicka O, and Brown MD. Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with {alpha}1-antagonist prazosin. Cell Tissue Res 293: 293–303, 1998.[CrossRef][Web of Science][Medline]
  109. Ziada A, Hudlicka O, and Tyler KR. The effect of long-term administration of {alpha}1-blocker pazosin on capillary density in cardiac and skeletal muscle. Pflügers Arch 415: 355–360, 1989.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
J. Physiol.Home page
I. M. Olfert, R. A. Howlett, K. Tang, N. D. Dalton, Y. Gu, K. L. Peterson, P. D. Wagner, and E. C. Breen
Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice
J. Physiol., April 15, 2009; 587(8): 1755 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. T. L. Van Duijnhoven, T. W. J. Janssen, D. J. Green, C. T. Minson, M. T. E. Hopman, and D. H. J. Thijssen
Effect of functional electrostimulation on impaired skin vasodilator responses to local heating in spinal cord injury
J Appl Physiol, April 1, 2009; 106(4): 1065 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Shi, M. Ishikawa, N. Kamei, T. Nakasa, N. Adachi, M. Deie, T. Asahara, and M. Ochi
Acceleration of Skeletal Muscle Regeneration in a Rat Skeletal Muscle Injury Model by Local Injection of Human Peripheral Blood-Derived CD133-Positive Cells
Stem Cells, April 1, 2009; 27(4): 949 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. R. Moore, J. E. Tang, N. A. Burd, T. Rerecich, M. A. Tarnopolsky, and S. M. Phillips
Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise
J. Physiol., February 15, 2009; 587(4): 897 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer
Insights into mechanisms behind arteriogenesis: what does the future hold?
J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Rebuttal from Drs. Thijssen and Hopman
J Appl Physiol, September 1, 2008; 105(3): 1007 - 1007.
[Full Text] [PDF]


Home page
J. Am. Podiatr. Med. Assoc.Home page
E. E. Klein, R. T. Crews, S. C. Wu, J. S. Wrobel, and D. G. Armstrong
CLEAR Cleat: A Proof-of-Concept Trial of an Aerobic Activity Facilitator to Reduce Plantar Forefoot Pressures and Their Potential in Those with Foot Ulcers
J Am Podiatr Med Assoc, July 1, 2008; 98(4): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Zhang, S. W. Sunnarborg, K. K. McNaughton, T. G. Johns, D. C. Lee, and J. E. Faber
Heparin-Binding Epidermal Growth Factor-Like Growth Factor Signaling in Flow-Induced Arterial Remodeling
Circ. Res., May 23, 2008; 102(10): 1275 - 1285.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. M. Costello, A. Rowlerson, N. A. Astaman, F. E. W. Anthony, A. A. Sayer, C. Cooper, M. A. Hanson, and L. R. Green
Peri-implantation and late gestation maternal undernutrition differentially affect fetal sheep skeletal muscle development
J. Physiol., May 1, 2008; 586(9): 2371 - 2379.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore
Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation
Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al.
Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography
Circulation, February 19, 2008; 117(7): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Ji, F. Mac Gabhann, and A. S. Popel
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. D. Mason, H. Rundqvist, I. Papandreou, R. Duh, W. J. McNulty, R. A. Howlett, I. M. Olfert, C. J. Sundberg, N. C. Denko, L. Poellinger, et al.
HIF-1{alpha} in endurance training: suppression of oxidative metabolism
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2059 - R2069.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. D. Kopple, H. Wang, R. Casaburi, M. Fournier, M. I. Lewis, W. Taylor, and T. W. Storer
Exercise in Maintenance Hemodialysis Patients Induces Transcriptional Changes in Genes Favoring Anabolic Muscle
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2975 - 2986.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. L. Haas, J. L. Doyle, M. R. Distasi, L. E. Norton, K. M. Sheridan, and J. L. Unthank
Involvement of MMPs in the outward remodeling of collateral mesenteric arteries
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2429 - H2437.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Milkiewicz, J. L. Doyle, T. Fudalewski, E. Ispanovic, M. Aghasi, and T. L. Haas
HIF-1{alpha} and HIF-2{alpha} play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle
J. Physiol., September 1, 2007; 583(2): 753 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Suhr, K. Brixius, M. de Marees, B. Bolck, H. Kleinoder, S. Achtzehn, W. Bloch, and J. Mester
Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans
J Appl Physiol, August 1, 2007; 103(2): 474 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Mac Gabhann, J. W. Ji, and A. S. Popel
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle
J Appl Physiol, February 1, 2007; 102(2): 722 - 734.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
L. Frydelund-Larsen, M. Penkowa, T. Akerstrom, A. Zankari, S. Nielsen, and B. K. Pedersen
Muscle: Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle
Exp Physiol, January 1, 2007; 92(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Iemitsu, S. Maeda, S. Jesmin, T. Otsuki, and T. Miyauchi
Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1290 - H1298.
[Abstract] [Full Text] [PDF]


Home page
Biol. Bull.Home page
M. von Dassow
Function-dependent development in a colonial animal.
Biol. Bull., August 1, 2006; 211(1): 76 - 82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Li, T. Akimoto, M. Zhang, R. S. Williams, and Z. Yan
Resident stem cells are not required for exercise-induced fiber-type switching and angiogenesis but are necessary for activity-dependent muscle growth
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1461 - C1468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Prior, J. M. Hagberg, C. M. Paton, L. W. Douglass, M. D. Brown, J. C. McLenithan, and S. M. Roth
DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1848 - H1855.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Zaldivar, J. Wang-Rodriguez, D. Nemet, C. Schwindt, P. Galassetti, P. J. Mills, L. D. Wilson, and D. M. Cooper
Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes
J Appl Physiol, April 1, 2006; 100(4): 1124 - 1133.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. S. Martins, A. Crescenzi, J. E. Stern, S. Bordin, and L. C. Michelini
Hypertension and Exercise Training Differentially Affect Oxytocin and Oxytocin Receptor Expression in the Brain
Hypertension, October 1, 2005; 46(4): 1004 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. Suzuki
Microvascular angioadaptation after endurance training with L-arginine supplementation in rat heart and hindleg muscles
Exp Physiol, September 1, 2005; 90(5): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
M. von Dassow
Flow and conduit formation in the external fluid-transport system of a suspension feeder
J. Exp. Biol., August 1, 2005; 208(15): 2931 - 2938.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Kojda and R. Hambrecht
Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy?
Cardiovasc Res, August 1, 2005; 67(2): 187 - 197.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Milkiewicz, O. Hudlicka, M. D. Brown, and H. Silgram
Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H336 - H343.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. H. Naylor, C. J. Weisbrod, G. O'Driscoll, and D. J. Green
Measuring peripheral resistance and conduit arterial structure in humans using Doppler ultrasound
J Appl Physiol, June 1, 2005; 98(6): 2311 - 2315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. G. Lloyd, B. M. Prior, H. Li, H. T. Yang, and R. L. Terjung
VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H759 - H768.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prior, B. M.
Right arrow Articles by Terjung, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prior, B. M.
Right arrow Articles by Terjung, R. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.